21.05.2012 • NewsCollaborationcooperationInnopharma Labs

Solvias, Innopharma Labs to Collaborate on PAT Solutions

The business unit process analytical technology (PAT) of the contract service provider Solvias has entered into collaboration with Innopharma Labs, to expand their services in the field of PAT.

The term of this collaboration allows Solvias to distribute Innopharma Labs' recently launched 3D particle characterizer worldwide.

In utilizing the 3D particle characterizer into its process analytical offer, Solvias' clients benefit from reduced formulation development and scale-up time plus increased process understanding and control during commercial manufacture. The eyecon 3D particle characterizer provides clients with high resolution images as well as particle size data in-line and in realtime.

The application will be presented during Achema in Frankfurt from June 18-22 at the Solvias booth N7 in hall 4.2.

 

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.